HomeIUI1 • ETR
add
Intuitive Surgical, Inc.
Previous close
€527.10
Day range
€522.00 - €558.40
Year range
€327.85 - €558.40
Market cap
207.70B USD
Avg Volume
231.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 2.04B | 16.88% |
Operating expense | 796.60M | 13.57% |
Net income | 565.10M | 35.94% |
Net profit margin | 27.73 | 16.32% |
Earnings per share | 1.84 | 26.03% |
EBITDA | 693.50M | 20.73% |
Effective tax rate | 14.96% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.23B | -34.65% |
Total assets | 17.74B | 20.60% |
Total liabilities | 2.07B | -1.12% |
Total equity | 15.68B | — |
Shares outstanding | 356.18M | — |
Price to book | 12.05 | — |
Return on assets | 8.39% | — |
Return on capital | 9.47% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 565.10M | 35.94% |
Cash from operations | 706.50M | 28.83% |
Cash from investing | -1.41B | -216.39% |
Cash from financing | 98.20M | 58.90% |
Net change in cash | -620.50M | -475.38% |
Free cash flow | 516.81M | 105.39% |
About
Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the Nasdaq-100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S., 1,199 in Europe, 1,050 in Asia, and 342 in the rest of the world.
Intuitive Surgical made its debut on the Fortune 500 list in 2024, ranking #497. Wikipedia
Founded
1995
Headquarters
Website
Employees
13,676
